Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elana A Maser

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Opinion in Gastroenterology|November 29, 2007
Pouch-ouchElana A Maser, Daniel H Present
Journal of Clinical Gastroenterology|February 8, 2013
Clinical presentation and outcomes of inflammatory bowel disease patients admitted to the intensive care unitChristina Ha, Elana A Maser, Asher Kornbluth
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2006
Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's diseaseElana A Maser, Renata Villela, Mark S Silverberg, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 22, 2008
Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitisElana A Maser, Deepthi Deconda, Simon Lichtiger, et al.
Inflammatory Bowel Diseases|May 15, 2013
High rates of metachronous colon cancer or dysplasia after segmental resection or subtotal colectomy in Crohn's colitisElana A Maser, David B Sachar, Danielle Kruse, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Opinion in Gastroenterology|November 29, 2007
Pouch-ouchElana A Maser, Daniel H Present
Journal of Clinical Gastroenterology|February 8, 2013
Clinical presentation and outcomes of inflammatory bowel disease patients admitted to the intensive care unitChristina Ha, Elana A Maser, Asher Kornbluth
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2006
Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's diseaseElana A Maser, Renata Villela, Mark S Silverberg, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 22, 2008
Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitisElana A Maser, Deepthi Deconda, Simon Lichtiger, et al.
Inflammatory Bowel Diseases|May 15, 2013
High rates of metachronous colon cancer or dysplasia after segmental resection or subtotal colectomy in Crohn's colitisElana A Maser, David B Sachar, Danielle Kruse, et al.
Pageof 1